Monograph Details
|
|
Ob/Gyn
> Infertility
|
|
Ganirelix acetate inj |
| Manufacturer |
|
Schering Corporation |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
GnRH antagonist. |
| Generic Name |
|
Ganirelix acetate 250micrograms per 0.5mL; soln for SC inj. |
| Indications |
|
Inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation. |
| Children |
|
Not applicable. |
| Adults |
|
After initiating FSH on day 2 or 3 of the cycle: 250micrograms once daily SC during the mid to late follicular phase. Continue until the day of hCG. |
| Contraindications |
|
Pregnancy (Cat.X). Nursing mothers. |
| Precautions |
|
Do complete gynecological and endocrinological exam first. Latex allergy. |
| Adverse Reactions |
|
Abdominal pain (gynecological), fetal death, headache, ovarian hyperstimulation syndrome, vaginal bleeding, injection site reactions, nausea, GI pain. |
| How Supplied |
|
Prefilled syringe—1, 5, 50 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
